RESEARCH FUNDING 1. Project Leader.The role and molecular mechanism of host cis element variation in HPV16 integration in the progression of cervical intraepithelial neoplasia. Project from the National Science Foundation of China. (81771529)2017-2020. 2. Project Leader.The application of micro colposcopy in the diagnosis of cervical cancer. （16CR3089B). Shanghai Shenkang Hospital Development Center. 2016-2019. 3. Early diagnosis and optimal treatment of cervical cancer in Shanghai women. Projects grants fromTechnology Committee of Shanghai. Project Leader for Cervical Intraepithelial Neoplasia(CIN).2016-2010. 4. Detection of chromosomal aberrations in the diagnosis of cervical precancerous lesions. Projects grants fromTechnology Committee of Shanghai. Project Leader (15411967700) 2015-2018. 5. Detection of high risk HPV-DNA integrated state prediction of cervical cancer. Project Leader.( 124119a3800,124119a3801) 2013-2015. 6. Detection of HPVE5 protein and E2 in patients with Cervical Intraepithelial Neoplasia and its role in the transformation of precancerous lesion. Project Leader. (20114150) 2012-2014. 7. Inhibition of angiogenesis in ovarian cancer by magnetic nanoparticle mediated PlGF receptor targeting.（No.1052nm01200）”Project Leader.2010-2012. 8. The exploratory study of Immune magnetic nanoparticles targeting diagnosis and in vivo imaging for ovarian cancer. Project from the National Science Foundation of China. Project Leader. 9. (No.30672232).2006-2009. 10. Quantum dots mark the specific peptide used for early diagnosis of ovarian cancer. Projects grants fromTechnology Committee of Shanghai. Project Leader.（074119647）”2007-2010 11. Magnetic nano-drugs for intraperitoneal chemotherapy of ovarian cancer”. Projects grants from Health Bureau of Shanghai. Project Leader. （2007147）. 2007-2010.

Patents: 1. Human single chain antibody of human placenta growth factor. Invention patent. 200910052435.X. 2. A Instrument for Measuring Cervix Size. Utility models of a patent. 201520925796.1.